National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

This is VAERS ID 1408687



Case Details

VAERS ID: 1408687 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-05-28
Onset:2021-06-01
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-06-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Anxiety, Fatigue, Hypoaesthesia, Paraesthesia
SMQs:, Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Hypoglycaemia (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PROZAC
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety; Lactation decreased
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021649054

Write-up: tingling in hands and feet; Tingling; Numbness/numbness feeling in legs and fingers; Tiredness/feeling totally fatigued; Anxiety/anxious; This is a spontaneous report from a contactable consumer (patient) received from the regulatory authority report number is GB-MHRA-WEBCOVID-202106021714065490-DMTOM, Safety Report Unique Identifier GB-MHRA-ADR 25407211. A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on 28May2021 (lot number and expiry date: unknown) as 1st dose, single for COVID-19 immunisation. Medical history included lactation decreased and anxiety. Patient has not had symptoms associated with COVID-19. Patient has not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not pregnant. Patient is not currently breastfeeding. Concomitant medications included fluoxetine hydrochloride (PROZAC) taken for anxiety, start and stop date were not reported. On 01Jun2021, the patient experienced tingling, numbness/numbness feeling in legs and fingers, tiredness, and anxiety. On unspecified date, the patient experienced tingling in hands and feet. Additional information: Tingling in hands and feet, alternates between hands and feet, numbness feeling in legs and fingers, feeling totally fatigued and anxious not knowing why she had these symptoms. Patient was waiting for a general practitioner (GP) appointment. The events were considered serious due to other medically important condition. Patient has not tested positive for COVID-19 since having the vaccine. Outcome of the event tingling in hands and feet was unknown, while for the remaining events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1408687


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166